pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …

pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …

pharmaceuticals to examine how incumbents respond to change in the threat of entry. In line with the entry deterrence motive …

-of-entry effects for pharmaceuticals indeed confirms advantages for the first mover ("first mover advantage" or "pioneer's advantage …